Market Place
Sourcing Support
Shape Shows AI Platform Advances For Precision RNA Editing
03 Oct 2024 //
GLOBENEWSWIRE
Shape Therapeutics Appoints David Epstein and Todd Simpson to Board of Directors
25 Jun 2024 //
GLOBENEWSWIRE
Shape`s RNAfix Achieves >90% Editing In Brain
08 May 2024 //
GLOBENEWSWIRE
Shape Therapeutics Appoints Matt Valentino As CPO
02 May 2024 //
GLOBENEWSWIRE
Shape to Showcase RNA Editing, AAV Producer Cell Line at ASGCT 2024
30 Apr 2024 //
GLOBENEWSWIRE
ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target
30 Nov 2023 //
GLOBENEWSWIRE
Otsuka pens AAV deal with Shape Therapeutics for eye gene therapies
08 Sep 2023 //
ENDPTS
ShapeTX Announces the Appointment of Adrian W. Briggs, Ph.D. As CTO
20 Jun 2023 //
GLOBENEWSWIRE
ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing
04 May 2023 //
GLOBENEWSWIRE
ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing
05 Jan 2023 //
GLOBENEWSWIRE
Lilly pays $75M to widen RNA editing deal with ProQR
23 Dec 2022 //
BIOPHARMADIVE
Shape Therapeutics named one of Fierce Biotech’s “Fierce 15” Companies of 2022
12 Sep 2022 //
GLOBENEWSWIRE
Shape Tx to Present Data on Advances in Its AI-Driven RNA Technology
12 May 2022 //
GLOBENEWSWIRE
Shape Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
06 Jan 2022 //
GLOBENEWSWIRE
Roche`s gene therapy plans take Shape with $3B-plus deal
25 Aug 2021 //
FIERCEBIOTECH
Shape Therapeutics raises $112 million series B for RNA-based gene therapies
26 Jul 2021 //
C&EN
EXCLUSIVE: Shape Therapeutics raises $112M in bid to make RNA editing a reality
16 Jul 2021 //
ENDPTS
Shape Therapeutics Secures $112 Million in Series B Financing
15 Jul 2021 //
GLOBE NEWSWIRE
Shape builds out RNA editing tech with a major $112M funding boost
15 Jul 2021 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.